Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
| Autor: | Molina, Jean-Michel, LaMarca, Anthony, Andrade-Villanueva, Jaime, Clotet, Bonaventura, Clumeck, Nathan, Liu, Ya-Pei, Zhong, Lijie, Margot, Nicolas, Cheng, Andrew K, Chuck, Steven L |
|---|---|
| Zdroj: | In The Lancet Infectious Diseases January 2012 12(1):27-35 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|